Weekly Clinical Updates

As infectious diseases such as SARS, Monkeypox, Polio, HIV, and Ebola travel the globe and garner media attention, Parasites Without Borders staff are curating resources in a timely, ongoing basis. We believe the information posted here is worthy of further examination by the science and medical communities. Our primary goal remains to bring the latest medical and biological information to the forefront for researchers and practicing physicians.

FIMRC Fundraiser x Parasites Without Borders Kicks Off This Spring

Throughout May, June, and July, donations made to Parasites Without Borders (PWB) will be matched by the organization and donated to Foundation for International Medical Relief of Children (FIMRC), for a total gift of up to $10,000. Founded in 2002 by Dr. Vikram D. Bakhru, FIMRC is a U.S.-based nonprofit organization that works to improve access to care through innovative, self-sustaining health programs. FIMRC works alongside communities to improve health from the ground up — including building necessary infrastructure, such as constructing or updating buildings; ensuring communities have access to a healthcare professional; and educating on preventive health.
Learn more at fimrc.org

SHOW YOUR SUPPORT - DONATE NOW

MicrobeTV Podcast

MicrobeTV is an independent podcast network for people who are interested in the life sciences. Our shows are about viruses, bacteria, parasites, evolution, immunology, and neuroscience.

MicrobeTV Podcast

July 17, 2020

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | Socio-demographic and epidemiological consideration of Africa's COVID-19 response: what is the possible pandemic course? | COVID-19 in Africa: the spread and response

View Updates

July 10, 2020

The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings | Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance

View Updates

July 3, 2020

FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic which has been caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). FDA is committed to providing timely guidance to support response efforts to this pandemic. FDA is issuing this guidance to assist sponsors in the clinical development and licensure of vaccines for the prevention of COVID-19.

View Updates

June 26, 2020

Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19 | Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study | Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report | Tocilizumab treatment for Cytokine Release Syndrome in hospitalized COVID-19 patients: survival and clinical outcomes

View Updates

June 17, 2020

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series | Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 (Press release) | Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants

View Updates

June 11, 2020

COVID-19 Vaccine Developers Search for Antibodies That ‘First Do No Harm’ | Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines

View Updates

« Anterior
1
…
47
48
49
50
51
…
53
Siguiente »

Situation Dashboards

World Health Organization (WHO)

Novel Coronavirus (COVID-19) Situation from World Health Organization (WHO)

View Dashboard

Johns Hopkins University (JHU)

Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at JHU

View Dashboard

COVID-19 in US and Canada

1Point3Acres Real-Time Coronavirus (COVID-19) Updates in US and Canada with Credible Sources

View Dashboard

Genomic Epidemiology COVID-19

Genomic Epidemiology of (COVID-19) Maintained by the Nextstrain team, enabled by data from GISAID.

View Dashboard

Weekly Clinical Updates

MicrobeTV Podcast

July 17, 2020

July 10, 2020

July 3, 2020

June 26, 2020

June 17, 2020

June 11, 2020

Situation Dashboards

World Health Organization (WHO)

Johns Hopkins University (JHU)

COVID-19 in US and Canada

Genomic Epidemiology COVID-19

Sources for COVID-19 Information

World Health Organization (WHO)

Centers for Disease Control, US

International Society for Infectious Diseases

This Week in Virology (TWIV)

Donate to Parasites Without Borders Today!